CTI BioPharma falls after bigger-than-expected loss

CTI Biopharma

09/08/2022 12:01

** Drugmaker CTI BioPharma Corp's shares  CTIC.O  fall 8.2%
to $6.48 before the bell - extends loss from Monday after
hitting over six-year high of $7.80 on Friday
    ** Reports a loss of 21 cents per share in Q2, higher than 
average estimate of loss of 20 cents per share -Refinitiv data
 urn:newsml:reuters.com:*:nPnKZS6Ja
    ** Bigger-than-expected Q2 loss partly due to increasing
cost of operation to $31.2 mln VS $19.5 mln
    ** Up to Friday's close, stock up ~185% YTD 

 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))